Atrial Fibrillation Market Is Expected to Reach US$14.8 Billion by 2019 - Rising Patient Count Represents Immense Potential Market for Manufacturers
Players such as St. Jude Medical, Inc., Johnson & Johnson Ltd., and Bristol-Myers Squibb Corp., have consistently led the global Atrial Fibrillation Market over the recent past. While the number of incoming innovations and pipeline treatment approvals will create a greater scope of growth for market players, the highly stringent regulations are expected to deter a sizeable number of new entrants.
View full press release